(505) 254-7784 pchelp@pcsanm.org
  • About Us
    • Mission Statement
    • Our Board
    • Organization Description
    • Donate
  • Contact Us
0 Items
Prostate Cancer Support Association of New Mexico
  • Home
  • Start Here
    • Beginner’s Guide
    • Next Steps
  • Meetings
  • Resources
  • Education & Info
    • Helpful Prostate Cancer-Related Websites
    • NM Cancer Resources & Support
    • News You Can Use
    • For Medical Professionals
  • Annual Conference
  • Newsletters
  • Early Detection
    • Early Detection
    • Free PSA Test
Select Page

Reduced Screening May Have Led to Rise in Advanced Prostate Cancer Diagnoses

by admin_63069 | Oct 1, 2025 | Related Topics

Changes in screening recommendations over a decade ago may have inadvertently resulted in later diagnosis of the most common cancer in men, a new study has found.

UChicago Medicine Emerges as a Global Leader in Focal Therapy Treatments

by admin_63069 | Sep 24, 2025 | Related Topics

The University of Chicago Medicine’s focal therapy program for prostate cancer has completed more than 300 procedures – a volume that ranks among the highest in the U.S.

FDA Accepts NDA for New Formulation of PSMA PET Injection in Prostate Cancer

by admin_63069 | Sep 10, 2025 | Related Topics

The new formulation should increase the batch size by approximately 50% and will offer the potential to expand access to patients in new geographic locations.

Psychological Side Effects for Common Prostate Cancer Treatment Raise Concerns

by admin_63069 | Aug 27, 2025 | Related Topics

Medical experts are pushing for more ongoing psychological support to be given to prostate cancer patients undergoing androgen deprivation therapy.

Outpatient Procedure Provides New Option for Prostate Cancer Care

by admin_63069 | Aug 13, 2025 | Related Topics

UC San Diego Health is the first and only hospital in the region to offer the minimally invasive treatment as an alternative to radiation or prostate removal.

Understanding Resistance to PSMA-Targeted Therapy

by admin_63069 | Jul 30, 2025 | Related Topics

This video highlights explains findings pointing to androgen receptor signaling and Wnt pathway activation as key correlates of poor response to therapy.
« Older Entries

What’s New

  • Reduced Screening May Have Led to Rise in Advanced Prostate Cancer Diagnoses
  • UChicago Medicine Emerges as a Global Leader in Focal Therapy Treatments
  • FDA grants fast track designation to HLD-0915 in mCRPC
  • FDA Accepts NDA for New Formulation of PSMA PET Injection in Prostate Cancer
  • Insurers’ Use of Artificial Intelligence (AI)

Disclaimers:

PCSANM provides education, information, and support, not medical advice. Please contact your physician for all your medical concerns. No copyrighted material belonging to others is knowingly used without permission. If any is inadvertently used without permission, please contact our office. Articles are selected from a variety of sources to give as wide a range of content as possible. PCSANM does not endorse or approve, and assumes no responsibility for, the content, accuracy, or completeness of the information presented.

2533 Virginia St. NE, Suite C Albuquerque, NM 87110

Phone: (505) 254-7784
Toll Free: (800) 278-7678
Fax: (505) 254-7786

Email: pchelp@pcsanm.org

  • Donate
  • Contact Us